New Age Ventures

Founded in 2009, New Age Ventures is a venture capital firm based in New York, New York. The firm seeks to make investments in healthcare, medical devices, digital health, cleantech, consumer tech, deep tech and applied artificial intelligence sectors.

12 past transactions

Spruce

Series B in 2022
Spruce develops a platform that enables individuals to receive services in their homes through a mobile app. Its services range from full housekeeping to a quick tidy up or a dog walk for a furry friend. The company was founded in 2016 and is headquartered in Austin, Texas.

Tilting Point

Private Equity Round in 2021
Founded in 2012, Tilting Point has grown to a staff of over 130 people in offices in New York, Boston, Barcelona, Kiev and Seoul. Our partnerships with development studios and publishers extend our reach to over a dozen countries. Our most successful games include Star Trek Timelines, Warhammer: Chaos & Conquest, and SpongeBob: Krusty Cook-Off. The last one achieved top 10 standing in 97 different countries when it launched, and is still enjoyed by millions of players, along with our extended catalogue of games. To achieve success, Tilting Point employs a data-driven approach to game development and user acquisition, while powering up existing live games for independent developers who may become closer partners on a new joint project as our relationship grows. Interested in working with us? Reach out by emailing hello@tiltingpoint.com Interested in working for us? Check our job listings at www.tiltingpoint.com/careers Want to learn more about us? www.tiltingpoint.com Facebook: facebook.com/tiltingpoint Twitter: twitter.com/TiltingPoint

Artract Medical Inc.

Pre Seed Round in 2021
Artract Medical hemodynamic assist device for the treatment of the heart. The Attract System is a passive hemodynamic assist device that is implanted percutaneously for the treatment of heart failure with preserved ejection fraction. Artract reduces left atrial blood pressure, easing shortness of breath.

Tabella

Pre Seed Round in 2020
Operating System for Religious Communities

BrainCheck

Series A in 2019
BrainCheck develops a health assessment and management tool to help people make decisions about their cognitive health. The company's application connects patients and care teams in both the concussion and dementia markets, and it also includes a screening tool and interactive tests that users can use on any mobile device or browser to assess brain health and receive results right away, allowing clinicians to track brain health for significant changes and share results with clinicians.

MetaSoul

Pre Seed Round in 2019
MetaSoul INC, an American Delaware company (January 2017) headquartered in New York, specializes in Emotion Synthesis for generative AI models. Our prediction is that by the end of this century, humans will engage in more conversations with sentient digital entities (AI) than with other humans. However, the current emotional technology fails to fulfill the fundamental human need for emotions. This is precisely where MetaSoul steps in to provide a solution. With fields as diverse as AI, metaverse, gaming, healthcare, and automotive, emotion synthesis is the ultimate upgrade for any product or service. In addition, the growing presence of AI, gaming, and virtual reality in society shows how critical and meaningful emotional interaction is to remove the barrier to widespread adoption. What sets EPU apart in the industry is that we're capable of generating any emotional state in an AI (LLM) from multimodal stimuli through wave computing. We also allow the AI to emotionally understand a situation by emotional reasoning and make a decision. Each unique MetaSoul (Persona) is linked to an EPUID to progress the development of its emotional personality over time, thanks to deep machine learning. MetaSoul’s breakthrough AI in advanced emotion synthesis dynamically layers emotion and empathy into any voice application and automated responses without the need for additional coding. Emotion synthesis technology not only controls voices but can also control the different facial micro expressions (FACS) and body languages of digital humans, robots, avatars, or NPC’s.’ faces in real-time using FACS What Make Us Unique MetaSoul holds a foundational patent family, granted by the United States Patent and Trademark Office, for perceiving and computing emotions in artificial intelligence (AI). Today, major tech companies in the US are using MetaSoul's technology when they deploy language and learning models (LLMs), as well as synthetic voices that can express dynamic tones, and life like avatars. As a result, MetaSoul has garnered significant attention.” Most of the AI research and innovation in this area has focused on detecting the emotional state by machine. Our unique, technology goes the next step by using AI to shape the machine’s cognitive appraisal and response, especially where voice and facial applications are involved. As a result, we are transforming the capabilities of Robots and AI, creating emotional states and synthetic emotion in for generative AI models. EPU is the industry’s first virtual emotion synthesis engine that delivers high performance machine emotion awareness. The EPU III family is transforming the capabilities of Robots and AI. MetaSoul has completed the deployment of the first EPU (emotional processing unit) in the cloud, a technology that creates emotional states and synthetic emotion in intelligent machines. The EPU is based on Patrick Levy-Rosenthal’s Psychobiotic Evolutionary Theory, extending Ekman’s theory by using twelve primary emotions identified in the psycho-evolutionary theory and pain/pleasure and frustration/satisfaction. Our revolutionary algorithms enable machines to respond to stimuli in line with one of the twelve primary emotions: anger, fear, sadness, disgust, indifference, regret, surprise, inattention, trust, confidence, desire, and joy. The Emotion recognition classifiers achieve more than 83 percent accuracy (ISEAR) on the conversation. The most innovative aspect of MetaSoul’ s emotion synthesis breakthrough is its real-time appraisal computation with reinforcement learning and Emotion Profile Graph (EPG) computation functionality allowing the AI or robot to experience 64 trillion possible distinct emotional states. Emotional stimuli are stored within the memory bank with their associated cognitive and physical state. The vEPU III has developed an EPG, which is used to register and develop over time a bank of emotional associations for each memory data within each intelligent machine. The EPG can communicate the data to other AI technologies to achieve a realistic range of expressions and interactions designed specifically for the user. The data allows the AI technologies to virtually understand/get to know the user and elicit the same emotional response. This technology allows an AI, robotic toy, or IoT device to develop a unique MBTI personality and emotion sensitivity (MetaSoul®) based on its user interactions and memories which will ultimately mean that no two have the exact same. Our emotion machine-learning cloud platform working with the EPU is built on years of research protected under issued patents for Special purpose processors (GPU). It becomes more emotionally intelligent with each interaction through symbolic reinforcement learning. In the near future, generative AI is poised to revolutionize the film industry by creating entire movies, going beyond just generating images or text. The demand for generative AI to produce synthetic emotions through character facial expressions, body language, and tone of voice, based on a deep understanding of the script and visual elements, will take center stage. MetaSoul, as the architect of emotion synthesis for AI, stands as the sole provider capable of offering a comprehensive solution in this domain.

Arcview Group

Series A in 2019
The Arcview Group, established in 2009 and based in San Francisco, California, is an investment and research company focused on the cannabis industry. It connects investors with cannabis-related businesses, facilitating financing for startups across various sectors, including cultivation, retail, and ancillary services. The company manages the Arcview Collective Fund, which invests in early-stage cannabis ventures, typically committing between $50,000 and $250,000 per investment. The Arcview Group also offers resources such as webinars to assist entrepreneurs in securing funding and provides insights into the growing cannabis market. Its initiatives include the Arcview Angel Network and the MyDispensary Mobile App, aimed at supporting the development of innovative cannabis businesses and enhancing industry connections.

Neosensory

Series A in 2019
Neosensory focus on sending a variety of data streams to the brain via the sense of touch. With so much unused real estate on the body, the skin presents huge potential for the delivery of new information. They are currently building the world’s first hearing assistive technology that enables people to listen with their skin.

High North Laboratories

Seed Round in 2018
High North Laboratories is a cannabis-specific company that is setting the standard for cannabis testing. It was entirely built on digital infrastructure to deliver faster and more reliable results in the shortest amount of time. The company offers cannabis growers and producers transparent product testing, ensuring that customers receive cannabis products.

OrthogenRx

Seed Round in 2015
OrthogenRx is a commercial-stage product development company that provides orthopedic medical devices for the treatment of musculoskeletal conditions. The business model utilizes exclusive supply and license agreements for products presently on the market ex-US and seeks generic product approval in the U.S. potentially saving the healthcare system billions in cost. The strategy utilizes existing regulations for an abbreviated regulatory approval for generic devices, analogous to generic drugs.

BootstrapLabs

Seed Round in 2014
Founded in 2008, BootstrapLabs, an Ares company, is a leading Venture Capital firm based in Silicon Valley and focused on Applied Artificial Intelligence. BootstrapLabs was one of the first VC firms to build an AI-first investment strategy and seeks to invest in visionary founders who solve some of today’s most important and valuable opportunities by applying Artificial Intelligence. BootstrapLabs is often the first institutional money and acts as a lead investor in the early stages, with follow-on capital at the growth stages. Through our Venture Studios and Venture Capital funds, we are investing in Artificial Intelligence applied to The Future of Work (FoW)/Productivity, Mobility, Health, Financial Infrastructure, Digital Infrastructure, Energy/Climate, and AI-enabling technologies. As entrepreneurs ourselves, we know it takes an experienced team amplified by a nurturing community to build successful companies, so we stand by our founders in good times and bad times, because the road to success is paved with setbacks, challenges, and lessons learned from past failures – and building something big is hard. Ultimately we believe technology should always be used to create a positive impact on society, and that founders should always place fellow humans at the heart of their vision.
TRANSCATHETER TECHNOLOGIES is developing a unique aortic valve implantation system that will increase the safety and durability of aortic valve implantation. The TRINITY repositionable transcatheter aortic valve system is at the forefront of next-generation transcatheter valve implantation technology. In the near future, transcatheter valve implantation will become the preferred therapy for aortic valve implantation, and TRANSCATHETER TECHNOLOGIES‘ goal is to provide the most advanced technology available.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.